Assessing climate risk to support urban forests in a changing climate

We thank Leslie Brandt and Gregory McPherson (USDA Forest Service, USA), Jakub Kronenberg (University of Lodz, Poland), Shawn Landry (University of South Florida, USA) and Per Anker Pedersen (Faculty of Landscape and Society, Norwegian University of Life Sciences) for their thoughts and contributions. MER, PR, SP and MGT thank Leigh Staas (Macquarie University) and funding from the Hort Frontiers Green Cities Fund, part of the Hort Frontiers strategic partnership initiative developed by Hort Innovation, with coinvestment from Macquarie University, Western Sydney University and the NSW Department of Planning, Industry and Environment and contributions from the Australian Government. DNB acknowledges support from the Research Council of Norway to the ENABLE project through the BiodivERsA COFUND 2015-2016 call for research proposals. BW acknowledges support from FORMAS (dia.nr 2016-20098). Finally, we thank the anonymous reviewers for their critical observations and thoughtful contributions that improved this work. The opinions and findings expressed in this paper are those of the authors and should not be construed to represent any official USDA or US Government determination or policy.Societal Impact Statement Globally, cities are planning for resilience through urban greening initiatives as governments understand the importance of urban forests in improving quality of life and mitigating climate change. However, the persistence of urban forests and the ecosystem benefits they provide are threatened by climate change, and systematic assessments of causes of tree dieback and mortality in urban environments are rare. Long-term monitoring studies and adaptive management are needed to identify and prevent climate change-driven failures and mortality. Research and monitoring when coupled with systematic forecasting will enable governments to incorporate climate change resilience into urban forestry planning. Future scenarios in which urban forests are resilient or in decline will depend on the management and planning actions we make today.The management of urban forests is a key element of resilience planning in cities across the globe. Urban forests provide ecosystem services as well as other nature-based solutions to 4.2 billion people living in cities. However, to continue to do so effectively, urban forests need to be able to thrive in an increasingly changing climate. Trees in cities are vulnerable to extreme heat and drought events, which are predicted to increase in frequency and severity under climate change. Knowledge of species' vulnerability to climate change, therefore, is crucial to ensure provision of desired ecosystem benefits, improve species selection, maintain tree growth and reduce tree mortality, dieback and stress in urban forests. Yet, systematic assessments of causes of tree dieback and mortality in urban environments are rare. We reviewed the state of knowledge of tree mortality in urban forests globally, finding very few frameworks that enable detection of climate change impacts on urban forests and no long-term studies assessing climate change as a direct driver of urban tree dieback and mortality. The effects of climate change on urban forests remain poorly understood and quantified, constraining the ability of governments to incorporate climate change resilience into urban forestry planning.Hort Frontiers Green Cities Fund, Hort Frontiers strategic partnership initiativeResearch Council of NorwaySwedish Research Council Formas 2016-2009

Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway

The clinical course and eventual outcome, or prognosis, of complex diseases varies enormously between affected individuals. This variability critically determines the impact a disease has on a patient’s life but is very poorly understood. Here, we exploit existing genome-wide association study data to gain insight into the role of genetics in prognosis. We identify a noncoding polymorphism in FOXO3A (rs12212067: T > G) at which the minor (G) allele, despite not being associated with disease susceptibility, is associated with a milder course of Crohn’s disease and rheumatoid arthritis and with increased risk of severe malaria. Minor allele carriage is shown to limit inflammatory responses in monocytes via a FOXO3-driven pathway, which through TGFβ1 reduces production of proinflammatory cytokines, including TNFα, and increases production of anti-inflammatory cytokines, including IL-10. Thus, we uncover a shared genetic contribution to prognosis in distinct diseases that operates via a FOXO3-driven pathway modulating inflammatory responses. PAPERCLIP

Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission

Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effectiveness of travellers being required to quarantine for 14-days on return to England in Summer 2020. We identified 4,207 travel-related SARS-CoV-2 cases and their contacts, and identified 827 associated SARS-CoV-2 genomes. Overall, quarantine was associated with a lower rate of contacts, and the impact of quarantine was greatest in the 16–20 age-group. 186 SARS-CoV-2 genomes were sufficiently unique to identify travel-related clusters. Fewer genomically-linked cases were observed for index cases who returned from countries with quarantine requirement compared to countries with no quarantine requirement. This difference was explained by fewer importation events per identified genome for these cases, as opposed to fewer onward contacts per case. Overall, our study demonstrates that a 14-day quarantine period reduces, but does not completely eliminate, the onward transmission of imported cases, mainly by dissuading travel to countries with a quarantine requirement

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Creating a 3D prototype to link the digital and physical

Students use Adobe Illustrator to make a 3D box to gain the foundational skills in using a robot. Illustrator acts as bridging software, combining the use of traditional CAD software with laser cutters. The ability to link the digital and physical world is a skill all Design and Engineering students will need. Taking an idea from the 3D modelling space and translating it to 2D and then taking it back to 3D in order to prototype is essential in learning this skill. This process allows students to quickly iterate their ideas and test how they hold up in the real world. The resources include: • A zip folder which includes the components needed to create a 3D box. This is quite a simple design but it allows students to easily modify it and focus on the skills they are learning rather than the design process. • A video on taking Solidworks components to a drawing and then to an Illustrtor file ready for lasercutting. This is extremely helpful as it teached students to quickly iterate their ideas and test how they hold up in the real world

Monorchidism in a Phenotypic Mare With a 64,XY, SRY-Positive Karyotype

Disorders of sexual development (DSD) are associated with atypical chromosomal, gonadal, or phenotypic sex. It is likely that the number of cases of DSD are underestimated in the equine population. Monorchidism in the horse is very rare. This case report describes the clinical assessment of a phenotypic mare with stallion-like behavior which led to the diagnosis of a DSD. A 4-year-old Quarter Horse mare presented in good body condition, with normal external genitalia for a mare, and normal mammary glands with two bilaterally symmetric teats. No uterus, cervix, or gonads were detected on transrectal palpation. Transrectal ultrasonography revealed a single gonad in the right dorsal abdomen with the morphologic appearance of a testicle. Presurgical hormonal evaluation revealed elevated serum testosterone and anti-Müllerian hormone (AMH) concentrations. The right gonad was successfully removed via standing exploratory laparoscopy and submitted for histopathology. No gonad was identified on the left side during laparoscopy. Histopathologic examination confirmed that the excised gonad was a testicle. Cytogenetic and molecular analysis revealed a 64,XY, SRY-positive chromosomal constitution. Hormonal evaluation 5 weeks after surgery revealed low serum testosterone and AMH levels. A diagnosis of monorchidism was based on ultrasound examination, laparoscopic exploration of the abdomen, removal of a single gonad, and a subsequent decrease in serum testosterone and AMH concentrations to basal levels. In summary, a combination of clinical signs, endocrine evaluation, chromosomal and molecular analysis, and histopathology can be used in the diagnosis of DSD conditions

New generation of embedded planar optics for in-situ, through-thickness and real-time strain measurements in carbon fiber reinforced polymer composites during the cure process

The first report of flat optical fiber embedded in carbon fiber reinforced polymer is given. The planar platform is used to monitor temperature and pressure changes inside an autoclave during the composite cure and has unique advantage of locking the slow axes to ply layers